Login / Signup

We are more than our omics.

Silvio Garattini
Published in: European journal of clinical pharmacology (2020)
Today, personalized medicine is essentially based on individual "omics." However there is a need to integrate this approach with a number of data such as pharmacokinetics, optimal dose and duration of drug treatments, age and gender differences, and drug interactions, which are relevant in terms of benefits and risks but are frequently unknown. This requires independent research that should be supported by governments in order to make personalized medicine a reality.
Keyphrases
  • single cell
  • electronic health record
  • big data
  • human health
  • risk assessment
  • adverse drug
  • emergency department
  • machine learning
  • drug induced
  • data analysis
  • artificial intelligence